Oncolytics Biotech

Price & Volume

Stats

52W Range	$0.71-$1.53
Market Cap	$71.4M
Shares Short	2M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$0.25

News

Yahoo Finance • 2 years ago

Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial

Yahoo Finance • 2 years ago

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

Yahoo Finance • 3 years ago

Oncolytics Biotech® Reports First Quarter 2022 Financial Results and Recent Operational Highlights

Yahoo Finance • 3 years ago

Oncolytics Biotech® Provides Positive Safety Update on the Third-Line Metastatic Colorectal Cancer Cohort of its Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial

About

CEO	Mr. Wayne F. Pisano M.B.A.
Address	322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	0